Effect of prior therapy with nilotinib or dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia

被引：0
|
作者：
Schleuning, M.
Scholten, M.
van Biezen, A.
Nagler, A.
Apperley, J.
Michallet, M.
Grigg, A.
Silver, R.
Niederwieser, D.
De Witte, T.
Olavarria, E.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [1] Effect of prior therapy with Nilotinib or Dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia
    Schleuning, M.
    Olavarria, E.
    Scholten, M.
    van Biezen, A.
    Michallet, M.
    Nagler, A.
    Hochhaus, A.
    Grigg, A.
    Silver, R.
    Schuld, P.
    Niederwieser, D.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S32 - S32
  • [2] Effect of prior therapy with nilotinib or dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia: a non-interventional prospective study by the CML subcommittee of the Chronic Leukaemia Working Party
    Schleuning, M.
    van Biezen, A.
    Hoek, J.
    Apperley, J. F.
    Maertens, J.
    Baccarani, M.
    Al Jurf, M.
    Michallet, M.
    Kuliczowski, K.
    Afanasyev, B.
    Finke, J.
    Olavarria, E.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S31 - S31
  • [3] Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib.
    Schleuning, Michael
    Scholten, Marijke
    van Biezen, Anja
    Nagler, Arnon
    Apperley, Jane F.
    Michallet, Mauricette
    Grigg, Andrew
    Silver, Richard T.
    Leitner, Armin
    Gratwohl, Alois
    Ekblom, Maria
    Khoury, H. Jean
    de Witte, Theo
    Olavarria, Eduardo
    BLOOD, 2010, 116 (21) : 970 - 970
  • [4] Effect of prior therapy with nilotinib or dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia; a non-interventional prospective study by the CML subcommittee of the chronic leukemia Working Party
    Schleuning, M.
    van Biezen, A.
    Hoek, J.
    Apperley, J.
    Aljurf, M.
    Volin, L.
    Markiewicz, M.
    Afanasyev, B.
    Finke, J.
    Michallet, M.
    Browne, P.
    Nagler, A.
    de Witte, T.
    Olavarria, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S35 - S35
  • [5] Outcome of allogeneic haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemia
    Koldehoff, M.
    Elmaagacli, A. H.
    Ditschkowski, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S428 - S428
  • [6] Outcome of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukaemia
    Devillier, R.
    Crocchiolo, R.
    Etienne, A.
    Prebet, T.
    Charbonnier, A.
    Fuerst, S.
    El Cheikh, J.
    D'Incan, E.
    Rey, J.
    Faucher, C.
    Blaise, D.
    Vey, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S100 - S100
  • [7] Relapse of chronic myeloid leukaemia after allogeneic stem cell transplantation:: outcome and prognostic factors
    Martínez, C
    de Soria, VGG
    Tomás, JF
    Parody, R
    Sureda, A
    Sanz, G
    Cañizo, C
    Díez, JL
    Boqué, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S61 - S61
  • [8] Imatinib therapy for chronic myeloid leukaemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
    Martinelli, G
    Palandri, F
    Amabile, M
    Bonifazi, F
    Bandini, G
    Benedetti, F
    Usala, E
    Angelucci, E
    Tiribelli, M
    Fanin, R
    Sorio, M
    Arpinati, M
    Testoni, N
    Falcioni, S
    Giannini, M
    Poerio, A
    Soverini, S
    Pane, F
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [9] Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia
    Koldehoff, M
    Elmaagacli, AH
    Steckel, NK
    Hlinka, M
    Ditschkowski, M
    Trenschel, R
    Peceny, R
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S236 - S236
  • [10] Outcome of haematopoietic stem cell transplantation in patients with atypical chronic myeloid leukaemia
    Koldehoff, M
    Beelen, DW
    Trenschel, R
    Steckel, NK
    Peceny, R
    Ditschkowski, M
    Hlinka, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2005, 35 : S234 - S234
12345